IXC
Click for more information
0.00% 6.5¢ invex therapeutics ltd

Ann: Phase III Clinical Trial Update and New IIH Market Analysis, page-100

  1. SSilverstein
    795 Posts.
    lightbulb Created with Sketch. 45
    clock Created with Sketch.
    28/06/23
    18:06
    Post #: 68519323
    This is my understanding also. Refer to phase II results
    IXC Price at posting: 22.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

BIO Biome posts record sales revenue of $13M in FY24 – up 80% vs pcp and higher than forecast
right-arrow Created with Sketch.
ITM iTech lifts MRE at Eyre Peninsula Graphite Project by 300%
right-arrow Created with Sketch.
AHK Ark Mines defines significant exploration target at Sandy Mitchell rare earths project
right-arrow Created with Sketch.
LRV Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%
right-arrow Created with Sketch.
EX1 Tryptamine Therapeutics completes maiden dosing of IV psilocin – a global first
right-arrow Created with Sketch.
AVA Ava Risk Group expands US presence with A$0.7M Substation Deal
right-arrow Created with Sketch.
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
(20min delay)
Last
6.5¢ 		Change
0.000(0.00%) 		Mkt cap ! $4.885M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 24 6.6¢
 

Sellers (Offers)

Price($) Vol. No.
7.7¢ 7950 1
View Market Depth
Last trade - 16.12pm 03/07/2024 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.